MatthewJoseph KDouglasMD

Clinical Trials

• New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) Start of enrollment: 2022 Dec 06

  Recruiting

  Not Applicable

• A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age Start of enrollment: 2023 Oct 19

  Active, not recruiting

  Phase 3

• Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension Start of enrollment: 2021 Jun 26

  Completed

  Phase 3

• Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension Start of enrollment: 2021 Jun 06

  Completed

  Phase 3

• Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD) Start of enrollment: 2023 Mar 02

  Completed

  Phase 2

• A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age Start of enrollment: 2023 Sep 25

  Active, not recruiting

  Phase 3

• A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain Start of enrollment: 2023 Oct 05

  Recruiting

  Phase 2

• A Study of LY3305677 in Participants With Obesity Or Overweight Start of enrollment: 2022 Nov 16

  Completed

  Phase 1

• A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes Start of enrollment: 2023 Jul 20

  Recruiting

  Phase 2

• A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age Start of enrollment: 2023 May 15

  Active, not recruiting

  Phase 2

• Study of Obeldesivir in Nonhospitalized Participants With COVID-19 Start of enrollment: 2023 Feb 08

  Completed

  Phase 3

• Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study Start of enrollment: 2022 Dec 16

  Active, not recruiting

  Phase 2, Phase 3

• A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19 Start of enrollment: 2023 Mar 28

  Active, not recruiting

  Phase 3

• Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants Start of enrollment: 2021 Nov 30

  Completed

  Phase 1

• ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD) Start of enrollment: 2021 Sep 30

  Completed

  Phase 1

• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. Start of enrollment: 2021 Aug 31

  Recruiting

  Phase 3

• Convalescent Plasma in Outpatients With COVID-19 Start of enrollment: 2020 Aug 11

  Completed

  Phase 3

• Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression Start of enrollment: 2022 Feb 28

  Recruiting

  Phase 2

• A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus Start of enrollment: 2023 Oct 24

  Active, not recruiting

  Phase 2

• A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight Start of enrollment: 2023 Nov 17

  Recruiting

  Phase 2

• A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight Start of enrollment: 2024 Feb 05

  Recruiting

  Phase 2

• A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight Start of enrollment: 2023 Nov 17

  Recruiting

  Phase 2

• Join now to see all